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Fish electric organ is a skelclal muscle homolog in which many muscic-specific genes are inhibited while acetylcholinc receptor is expressed athigh 
levels. The molecular mechanisms underlying this discoordinate r gulation have not yet been explored. We have obtained partial sequences for 
MyoD. myogenin, and myf5 from Torpedo caiifort~ica and have measured their mRNAs in several organs. using ribonuclease protection. We have 
found that MyoD and myf5 are expressed atcomparable vels in muscle and electric organ, whereas myogenin transcripts could not be detcctcd 
in either tissue. Acetylcholine receptor a subunit mRNA, on the other hand. is two orders of magnitude more abundant in electric tissue. We 
conclude that neither the loss or’ contractile proteins from, nor the enhanced expression of acetylcholine receptor genes in, the differentiating 
electrocyte is a simple consequence of the abundance of myogenic factor messages. 
Myogenic factor; Electric organ; Skeletal muscle; Regulation: Acetylcholinc receptor; Torpedo cufijbrnicu 
1. INTRODUCTION 
An analysis of the control of acetylcholine receptor 
(AChR) gene expression is important for an under- 
standing of how myogenic cells differentiate and how 
they respond to neural signals, Like many genes that are 
specifically expressed in muscle, all AChR subunit genes 
analysed to date have been found to contain CANNTG 
elements (E boxes; MEFl sites) which are recognized by 
the members of the MyoD family of regulatory proteins 
[l-7]. That AChR promoters hould share cis elements 
with other muscle-specific genes is perhaps not surpris- 
ing, since many of these genes are coordinately upregu- 
lated during differentiation. However, AChR expres- 
sion does not always parallel expression of other muscle 
genes. For example, genes coding for the extrajunc- 
tional or embryonic receptor (cc&~ are strongly acti- 
vated following denervation of mature muscle [8] when 
expression of other muscle genes is little changed. An 
extreme case of the discoordinate control of the expres- 
sion of AChR and of a large fraction of muscle-specific 
proteins is the electric tissue of electric fish. The electric 
organ is a skeletal muscle homolog that forms during 
embryonic development. This process has been studied 
in detail in Torpedo marmoram [9-111. Cells that give 
rise to the organ initially appear as myoblasts that fuse 
to form elongated myotubes with. a cross-striated con- 
tractile apparatus, before they lose their myofibrils and 
flatten into mature electrocytes. These electrocytes are 
highly specialized cells that retain the apparatus for 
chemical excitability and certain proteins serving ancil- 
lary fi;nctions such as electrogenic ion pumps. How- 
ever, they have ceased to express components of the 
myofibrils which in striated muscle comprise the bulk 
of the cellular protein. How the genes coding for these 
proteins are turned off while those coding for AChR 
subunits maintain or even increase their activity is an 
intriguing problem in muscle gene control. An investi- 
gation of this transition may shed light on mechanisms 
of receptor egulation and more generally on the control 
of the muscle phenotype. 
As a first step in an analysis of electrocyte gene cun- 
trol we have prepared probes for myogenic factors from 
Torpedo californica (a close relative of Torpedo manno- 
era) and measured factor transcript levels in skeletal 
muscle and electric tissue. 
2. MATERIALS AND METHODS 
9.1. Probes@ Torpedo californica nrRNAs 
Abbreviulions: AChR, acetylcholinc re!ptcr; PCH, polymerase chain 
reaction. 
Correspondmcc address: J. Schmidt, Department of Biochemistry and 
Cell Biology, State University of New York at Stony Brook, Stony 
Brook, NY 11794, USA. Fax: (I) (516) 632 8575. 
Two degenerate oligonucleotides, cc~tccTGCCTlI(UI?ITGG- 
GCITGCAA(A/G)IIITGCAA(A/G)(A/C)GIAA and czggatccAT(A/ 
G)TAI(C/T)(G~)IATlGC(~G)I(&T)IC(G~IAGIAT(~)TCIA- 
C(CiT)TT, corresponding to regions hared by the four known myo- 
genie factors, were synthesized (Oligos Inc., Guilford, Cl% The up 
stream oligonucleotide was designed to encode CLPWACKXCKRK, 
a stretch of twelve amino acids just ups!ream of the basic DNA 
binding region, of which ten nre conserved in a!1 myogenic genes from 
Drosophila to Homo. The downstream primer encodes KVEILR(NI 
S)AIRY, a port.ion or helix 11 of the dimeriation domain. One fig of 
Torpedo calfirnica genomic DNA was amplified by the po1ymcr;is-e 
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chain reaction (PCR) under the following conditions: 5 cycles - 95”C/I 
min, 37OC/I min, ramp12 min, 72”C/30 s: 25 cycles - 94OC/I min, 
S5OC/! min, 72”C/l s. The flanking RarlrHl sites generated by the 
primers in the resulting 21C-bp product were cleaved, and the frap 
mcnts insencti into the M 13 vector PhagcScript SK (Stratagene, La 
Jells. CA). Individual plaques were Brown up and sequenced. using 
Sequrnasc 2.0, following the manufacturer’s recommendations (U.S. 
Biochemical, Cleveland, OH), to ascertain their identities. Inserts cor- 
responding to MyoD, myogenin, and myf5 were PCR-nmplified with 
the flanking universal Reverse and -20 primers, and transcribed, 
using the appropriate phage RNA polymerase to gencrate ‘zP-labellcd 
antisense riboprobe. A template for the synthesis of Turpedo cnli/ur- 
hx~ AChR u-subunit riboprobe was constructed by purifying a IOS- 
bp SuuSAl-&RV fragment from the plasmid DOLo: [I 21 and sub- 
cloning it in the Bluescript plasmid pKSII- (Stratagene. La Jolla, CA). 
2.2. Pwpnralion nrul nnalysis UJIIIRNA 
Torpedo culijoruicu organs, obtained from an adult fisb and immc- 
diately frozen in liquid nitrogen, were purchased from Marinus, Inc. 
(Long Beach, CA), Total RNA was extracted by a protocol adapted 
from the guanidinium isothiocyanate method of Chirgwin et al. [I 31. 
mRNA levels were measured by ribonuclease protection assay essen- 
dally as described [14]. The protected bands in the gels were visualized 
by autoradiography and quantified with a E;tascopc GO3 blot analyze1 
(Betagcn. Waltham, MA). 
2.3. Syniimis of cDNA 
Five & of totai RNA were reverse-transcribed in 50 ,ul of bufGr 
containing 50 mM Tris-HCI pH 8.3, 75 mM KCI, IQ mM MgC&, 0.5 
mM spermidine, IO mM DTT, 4 mM Na pyrophospbate, I mM 
dNTPs, 50 units RNasin (Promcga, Madison. WI), 2.5 yg random 
hexamer, and 50 units AMV reverse transcriptase. The reaction was 
allowed to proceed at 42°C for one hour, after which the enzyme was 
heat-inactivated. PCR amplifications were subsequently done on I-PI 
aliquots. 
2.4. Oolarion of gcrrornic DNA 
Frozen electric tissue was pulverized with a mortar and pestle in the 
presence of liquid nitrogen. The powder was resuspended in a solution 
containing 10 mM Tris-HCI pH 7.4, 10 mM EDTA, I50 mM NaCI, 
0.4% SDS, and 1 mdml protcinase K. It was then incubated at GYC 
for two hours, followed by gentle rocking overnight at 37°C. The 
solution was extracted twice with phenol/chloroform and once with 
chloroform. One-twentieth ofone volume of 3 M sodium acetate and 
two volumes of ethanol were added. Genomic DNA was spooled on 
a glass pipette and rinsed in 70% ethanol followed by 100% ethanol. 
The DNA was allowed to briefly air dry and was dissolved in IO mM 
TrismHCI pH 7.4, I mM EDTA. 
3. RESULTS AND DISCUSSION 
3.1. Idet@icuGon of Torpedo californica myogenic fuc- 
tar genes 
To determine which MyoD-related genes Torpedo 
cal@rnica might possess we amplified genomic DNA 
by PCR, using as primers two highly conserved regions 
in the DNA binding-dimerization motif that have ena- 
bled us previously to isolate gene fragments of the four 
chicken myogenic factors [ 151. The forward primer en- 
codes the cysteine-rich sequence (CLPWACKXCKRK) 
just ‘upstream of the basic DNA-binding region; the 
reverse primer corresponds to Helix 11, the region neces- 
sary for dimerization. The former is unique to the myo- 
genie factor family and is the most highly conserved 
region in mammals, while the latter is moderately con- 
served through the entire HLH super-family [16]. 
Genomic DNA which should contain potential target 
sequences at comparable frequency was chosen as tem- 
plate for PCR instead of cDNA because the extent of 
expression of the myogenic genes in either muscle or 
electric tissue was unknown. The primers amplify a 194- 
bp region that is not interrupted in any mammalian 
gene for which the genomic structure is known [17], 
although an intron occurs in the Drosophila gene [18]. 
Three distinct sequences were identified in the initial 
pool of amplified fragments. Each occurred with ap- 
proximately equal frequency. Translation of the nucleo- 
tide sequences howed these to correspond to MyoD, 
myogenin, and myf5; the Torpedo californica sequences 
differ from their mammalian counterparts by very few, 
conservative substitutions (Fig. 1). A phylogenetic anal- 
ysis of the human myogenic factors suggests that the 
gene duplication that gave rise to herculin and myo- 
genin preceded that which generated MyoD and myf5 
and that, consequently, herculin should be present in 
the Torpedo cuIifornica genome. However, herculin 
could not be identified by PCR in either genomic or 
cDNA preperations even when gene-specific primers 
were used. 
3.2. Tissue expression of Torpedo californica myogettic 
factor mRNA 
In higher vertebrates, the myogenic factors act as 
muscle-specific transactivatars, and their expression is 
restricted to myogenic ells. They all share the ability to 
convert fibroblasts to muscle cells, but in vivo are ex- 
pressed in the myogenic lineage at different times of 
development and consequently may be assumed to serve 
specific rather than completely exchangeable functjons 
[ 191. To assess their tissue expression i  Torpedo cal@r- 
nica, total P.NA was isolated from several different or- 
gans of an adult specimen and assayed for specific 
mRNAs. The MyoD message isexpressed in both myo- 
genie tissues in approximately equal amounts (1.6 fmol/ 
mg RNA). Message coding for myf5 is present in muscle 
at similar levels (1.6 fmol/mg RNA), but is somewhat 
less abundant in electric tissue (0.8 fmol/mg RNA). No 
myogenin mRNA was detected in either tissue at this 
stage. Very low levels could have escaped etection; the 
limits of sensitivity of the assay are estimated at approx- 
imately 0.03 fmol per mg total RNA. Quantification of 
receptor a-subunit message revealed levels in electric 
organ (28 fmol/mg RNA) exceeding those in skeletal 
muscle by approximately 300-fold. No evidence for the 
expression of myogenic factors (or receptor a subunit) 
was found in any of the other organs tested, including 
cardiac muscle (Fig. 2). 
No obvious candidate for transactivator of the recep- 
tor GI subunit gene emerges from these observations. 
Both MyoD and myf5 are expressed to a comparable 
degree in the two tissues and may be involved in the 
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Fig. l_ Aligned predicted amino acid sequences of Torpedo caliJort~icu 
myogenic factor bHLH regions, Torpedo culiJorttica genomic DNA 
was PCR amplified as described in section 2. The deduced amino acid 
sequences are shown for the three unique amplified DNA fragments. 
By alignment with their human counterparts. from which they dilTer 
in one, 2, and 5 residues, they are identified as the basic region/helix 
I/loop segments of MyoD, myogcnin, and my6 rcspcctively. 
transcription of the muscle-specific genes that remain 
active when myofibers become electrocytes including 
the genes coding for AChR subunits. MyoD could be 
involved as it may also regulate the expression of the 
junctional type of AChR in higher vertebrates where it 
is present in innervated muscle [20-221 and has been 
shown in cotransfection experiments o activate the pro- 
moters of the chick x [2], and mouse and chick y [4,7] 
subunit genes. The large quantitative difference in a- 
subunit mRNA levels between muscle and electroplax 
would have to be accounted for by some as yet un- 
known regulatory feature (e.g. larger amount or higher 
activity of the factor protein, stabilization of receptor 
messages, etc.). 
The apparent absence of myogenin deserves a com- 
ment. In mammals, myogenin is expressed in embryomc 
muscle, but then virtually disappears during early post- 
natal development. Upon denervation it is strongly 
upregulated, about 2O- to 40-fold in rat [22] and mouse 
[20,21], and about 200-fold in the chick where it could 
play a role in the dramatic proliferation of the extra- 
junctional or embrpnnic type of AChR underlying den- 
ervation supersensitivity [l !I]. Perhaps the junctional 
type of receptor does not require myogenin for expres- 
sion and instead relics primarily on MyoD which is 
present in innervated muscle, and is only moderately 
upregulated upon nerve section, both in rat (-4-fold, [20]) 
and in chick (-2- to T-fold [IS]). Although the Torpedo 
cair$micu electric tissue AChR comprises a y subunit, 
this is a historical quirk of nomenclature rather than an 
indication of the embryonic nature of the receptor. The 
Torperfo calijbrnica y subunit resembles the mammalian 
E subunit in sequence [23], phosphorylation sites [24], 
and immunoreactivity [25]; the electric organ receptor 
also has the high conductance and short open time char- 
acteristic of an adult endplate receptor in higher verte- 
MyoD 
myogenin 
myf5 
AChR a 
18s I-RNA 
Fig. 2. Expression of myognic factors in various tissues of adult 
Torpedo cul~firnicu. Total RNA (30 rg) from each of the indicated 
tissues was hybridized separately with MyoD, myogcnin, myf5. and 
AChR a subunit riboprobe and subjected to nuclease protection as 
described in section 2. Rclativc quantity and integrity of total RNA 
was determined by electrophoresis of three yg from each tissue in a 
formaldehyde agarosc gel in the presence of ethidium bromide [271. 
The iSS rRNA band is shown st the bottom. 
brates [26]. Therefore, if the electroplax receptor is of 
the junctiona! type which the biochemical and biophys- 
ical data seem to suggest, then the two tissues under 
investigation clearly would not need a factor which in 
higher vertebrates i linked to the appearance of extra- 
junctional receptors. 
At present we do not know the molecular mecha- 
nisms underlying the transdifferdntiation f myotubes 
into electrocytes, and in particular the processes that 
account for the down-regulation of the myofibrillar pro- 
teins and for the enhanced expression of AChR. Our 
study of the expression of MyoD, myogenin, and myf5 
indicates that transcript levels of these myogenic factors 
and cellular phenotype are not correlated and that other 
factors (e.g. herculin or proteins outside the MyoD fam- 
ily) and events (e.g. posttranscriptional regulation) must 
be invoked and remain to be identified in future investi- 
gations. 
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